BioStem Technologies Inc (NAS:BSEM)

Q1 2026 Biostem Technologies Inc Earnings Call Transcript

May 14, 2026 / 08:30 PM GMT

Release Date Price: $5.03 (-0.81%)

Transcript

Key Points

Positve

BioStem Technologies Inc (BSEM) completed a significant acquisition in January 2026, transitioning from a physician office-focused business to a hospital-focused business, which is expected to drive long-term growth.
The acquisition added a new portfolio of perinatal tissue allografts and expanded the company's addressable market, increasing exposure to commercially insured patient populations.
BioStem Technologies Inc (BSEM) has confidentially submitted its Form 10 to the SEC, aiming for an uplisting to NASDAQ, which could enhance visibility, attract top talent, and improve trading liquidity.
The company has successfully retained the acquired sales team with limited turnover and nearly doubled the size of its direct sales team, positioning it for increased utilization and new customer acquisition.
BioStem Technologies Inc (BSEM) has established major GPO contracts, providing favorable access to hospital systems and expanding its product portfolio within those accounts.

Negative

The company experienced a sequential decrease in gross margin from 97% to 61% due to the product shift to Neox and Clarix products under the manufacturing supply agreement.
Operating expenses for the first quarter were $12.6 million, driven by the addition of the acquired workforce and one-time expenses related to the acquisition and uplisting process.
The physician office market continues to face disruptions due to CMS reimbursement changes and aggressive auditing, causing clinicians to hesitate in treating patients in that setting.
BioStem Technologies Inc (BSEM) anticipates a decline in gross margins during the year as it works through pre-existing inventory purchased at a discount.
The company faces challenges in integrating and scaling its commercial organization, with new hires taking time to ramp up to full productivity.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BSEM.PK - Biostem Technologies Inc
Q1 2026 Biostem Technologies Inc Earnings Call
May 14, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, thank you for standing by. My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to the BioStem Technologies first quarter 2026 earnings call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during this time, simply press star, followed by the number one on your telephone keypad. If you would like to withdraw your question, press *1 again.

Thank you, and I would now like to turn the conference over to Hannah Jeffrey, Investor Relations. You may begin.

------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.